Alejandro Pérez-Fernández

Dr. Alejandro Pérez-Fernández

Dermaclaim Lab, Valencia, Spain

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2018 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
RPRodrigo Prieto-Bermejo
Rodrigo Prieto-Bermejo
MRMarta Romo-González
Marta Romo-González
Alejandro Pérez-FernándezAlejandro Pérez-Fernández
Alejandro Pérez-Fernández
CICarla Ijurko
Carla Ijurko
Angel Hernandez-HernandezAngel Hernandez-Hernandez
Angel Hernandez-Hernandez
Oxidative stress is related to ageing and degenerative diseases, including cancer. However, a moderate amount of reactive oxygen species (ROS) is required for the regulation of cellular signalling and gene expression. A low level of ROS is important for maintaining quiescence and the differentiation potential of haematopoietic stem cells (HSCs), whereas the level of ROS increases during haematopoietic differentiation; thus, suggesting the importance of redox signalling in haematopoiesis. Here, we will analyse the importance of ROS for haematopoiesis and include evidence showing that cells from leukaemia patients live under oxidative stress. The potential sources of ROS will be described. Finally, the level of oxidative stress in leukaemic cells can also be harnessed for therapeutic purposes. In this regard, the reliance of front-line anti-leukaemia chemotherapeutics on increased levels of ROS for their mechanism of action, as well as the active search for novel compounds that modulate the redox state of leukaemic cells, will be analysed.

1 December 2014 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
JSJosé Luis Sardina
José Luis Sardina
GLGuillermo López-Ruano
Guillermo López-Ruano
RPRodrigo Prieto-Bermejo
Rodrigo Prieto-Bermejo
BSBeatriz Sánchez-Sánchez
Beatriz Sánchez-Sánchez
Alejandro Pérez-FernándezAlejandro Pérez-Fernández
Alejandro Pérez-Fernández
Angel Hernandez-HernandezAngel Hernandez-Hernandez
Angel Hernandez-Hernandez

14 February 2019 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
Alejandro Pérez-FernándezAlejandro Pérez-Fernández
Alejandro Pérez-Fernández
GLGuillermo López-Ruano
Guillermo López-Ruano
RPRodrigo Prieto-Bermejo
Rodrigo Prieto-Bermejo
CICarla Ijurko
Carla Ijurko
MCMaría Campelo
María Campelo
Angel Hernandez-HernandezAngel Hernandez-Hernandez
Angel Hernandez-Hernandez
The differentiation-based therapy for acute promyelocytic leukemia (APL) is an inspiring example for the search of novel strategies aimed at treatment of other subtypes of acute myeloid leukemia (AML). Thus, the discovery of new molecular players in cell differentiation becomes a paramount research area to achieve this goal. Here, the involvement of the protein tyrosine phosphatases SHP1 and SHP2 on leukemic cells differentiation is shown, along with the therapeutic possibilities of their targeting to enhance the differentiation induction effect of phorbol esters. The oxidation status and enzymatic activity of SHP1 and SHP2 during PMA-induced differentiation of HEL cells was evaluated. Additionally, the effects of RNAi-mediated downregulation of these phosphatases on cell differentiation was studied. Afterwards, the impact of chemical inhibition of SHP1 and SHP2 on differentiation both in the presence and absence of phorbol esters was tested. Finally, the anti-leukemic potential of phorbol esters and chemical inhibitors of SHP1 and SHP2 was addressed in several AML model cell lines, a xenograft mouse model and AML primary cells in vitro. An increase of oxidation with a concomitant decrease of activity was observed for both phosphatases at the onset of PMA-induced differentiation. Consistently, silencing of these proteins favored the process, with an enhanced effect upon their simultaneous downregulation. Moreover, the proteins SRC and β-catenin were identified as downstream targets of SHP1 and SHP2 in this context. In agreement with these findings, chemical inhibition of the phosphatases promoted cell differentiation itself and enhanced the effect of phorbol esters. Interestingly, treatment with the phorbol ester prostratin and the dual inhibitor of SHP1 and SHP2 NSC87877 synergistically hampered the proliferation of AML cell lines, prolonged the survival of xenografted mice and reduced the clonogenic potential of AML primary cells. SHP1 and SHP2 are relevant mediators of differentiation in AML cells and their inhibition either alone or in combination with prostratin seems a promising differentiation-based therapeutic strategy against different subtypes of AML beyond APL.

5 November 2023 in International Journal of Cosmetic Science
Verified
Journal Article
Open access
SDShaher Duchi
Shaher Duchi
PTPaloma Rebollo Torregrosa
Paloma Rebollo Torregrosa
AHAkram Hajuj
Akram Hajuj
DMDanit Molho
Danit Molho
RSRawya Shkoor
Rawya Shkoor
Alejandro Pérez-FernándezAlejandro Pérez-Fernández
Alejandro Pérez-Fernández
Objective: To develop and evaluate the efficacy of WS Biotin, a novel water‐soluble form of D‐Biotin, for cosmetic use.Methods: A new encapsulated form of D‐Biotin was developed with the purpose of improving the water solubility of biotin. This novel form of encapsulated biotin was characterized by its physicochemical properties: particle size, D‐Biotin content and solubility in water. Also, proliferation and gene expression in vitro tests in cell culture were performed to evaluate its effectiveness in promoting hair growth, an ELISA test was conducted for hair keratinization and skin lightening property was tested by analysing the intracellular melanin content.Results: The developed WS Biotin microcapsules exhibit a particle size range of 2–30 μm with D‐Biotin content of ~50% (w/w). The water solubility of WS Biotin was found to be 20‐fold greater than free biotin. The obtained in vitro results indicated that WS Biotin enhances the expression of hair‐related keratins in hair follicle keratinocytes, as well as the expression of hair growth‐promoting genes in dermal papilla cells. Moreover, the melanin content in UVA‐exposed epidermal melanocytes was reduced upon exposure to WS Biotin.Conclusion: In this work, a novel form of encapsulated biotin, WS Biotin, was developed in order to improve the water solubility of free biotin and was found to be effective for cosmetic use in both hair and skin applications.

9 January 2020 in Haematologica
Verified
Journal Article
Open access
PDF file
RPRodrigo Prieto-Bermejo
Rodrigo Prieto-Bermejo
MRMarta Romo-González
Marta Romo-González
Alejandro Pérez-FernándezAlejandro Pérez-Fernández
Alejandro Pérez-Fernández
IGIgnacio García-Tuñón
Ignacio García-Tuñón
Manuel Adolfo Sanchez-MartinManuel Adolfo Sanchez-Martin
Manuel Adolfo Sanchez-Martin
Angel Hernandez-HernandezAngel Hernandez-Hernandez
Angel Hernandez-Hernandez
The regulation of protein function by reversible oxidation is increasingly recognized as a key mechanism for the control of cellular signaling, modulating crucial biological processes such as cell differentiation. In this scenario, NADPH oxidases must occupy a prominent position. Our results show that hematopoietic stem and progenitor cells express three p22phox-dependent NADPH oxidases members (NOX1, NOX2 and NOX4). By deleting the p22phox coding gene (Cyba), here we have analyzed the importance of this family of enzymes during in vivo hematopoiesis. Cyba-/- mice show a myeloid bias, and an enrichment of hematopoietic stem cell populations. By means of hematopoietic transplant experiments we have also tried to dissect the specific role of the NADPH oxidases. While the absence of NOX1 or NOX2 provides a higher level of reconstitution, a lack of NOX4 rendered the opposite result, suggesting a functional specificity among the different NADPH oxidases. Cyba-/- cells showed a hampered activation of AKT1 and a sharp decrease in STAT5 protein. This is in line with the diminished response to IL-7 shown by our results, which could explain the overproduction of immunoglobulins observed in Cyba-/- mice.

Verified
Journal Article
Open access
PDF file
RPRodrigo Prieto-Bermejo
Rodrigo Prieto-Bermejo
MRMarta Romo-González
Marta Romo-González
Alejandro Pérez-FernándezAlejandro Pérez-Fernández
Alejandro Pérez-Fernández
MGMaría Carmen García-Macías
María Carmen García-Macías
CSCarmen Sánchez-Bernal
Carmen Sánchez-Bernal
Angel Hernandez-HernandezAngel Hernandez-Hernandez
Angel Hernandez-Hernandez
Haematopoiesis is a paradigm of cell differentiation because of the wide variety and overwhelming number of mature blood cells produced daily. Under stress conditions, the organism must adapt to a boosted demand for blood cells. Chronic granulomatous disease (CGD) is a genetic disease caused by inactivating mutations that affect the phagocyte oxidase. Besides a defective innate immune system, CGD patients suffer from recurrent hyper-inflammation episodes, circumstances upon which they must face emergency haematopoiesis. The targeting of Cybb and Ncf1 genes have produced CGD animal models that are a useful surrogate when studying the pathophysiology and treatment of this disease. Here, we show that Cyba−/− mice spontaneously develop granuloma and, therefore, constitute a CGD animal model to complement the existing Cybb−/− and Ncf1−/− models. More importantly, we have analysed haematopoiesis in granuloma-bearing Cyba−/− mice. These animals showed a significant loss of weight, developed remarkable splenomegaly, bone marrow myeloid hyperplasia, and signs of anaemia. Haematological analyses showed a sharped decrease of B-cells and a striking development of myeloid cells in all compartments. Collectively, our results show that granuloma inflammatory lesions dramatically change haematopoiesis homeostasis. Consequently, we suggest that besides their defective innate immunity, the alteration of haematopoiesis homeostasis upon granuloma may contribute to the dismal outcome of CGD.